Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
Kenya tourist helicopter crash kills seven
US, South Korea to cut length, scope of military drills after Trump order
Central African Republic gold mine collapse kills at least 100
Israeli airstrike kills nine Palestinians at Gaza police station
Thai schools hold shooting response drills after deadly school attack
